Filing Details
- Accession Number:
- 0001179110-11-012087
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-11 16:19:32
- Reporting Period:
- 2011-08-10
- Filing Date:
- 2011-08-11
- Accepted Time:
- 2011-08-11 15:19:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1107421 | Ziopharm Oncology Inc | ZIOP | Services-Specialty Outpatient Facilities, Nec (8093) | 841475642 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1301268 | Wyche Fowler | 701 A Street Ne Washington DC 20002 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.001 Par Value | Acquisiton | 2011-08-10 | 5,000 | $5.19 | 72,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock, $.001 Par Value | Director Stock Option (right to buy) | $4.31 | 2006-12-22 | 2014-12-22 | 15,029 | 15,029 | Direct |
Common Stock | Director Stock Option (riht to buy) | $5.01 | 2006-04-26 | 2016-04-26 | 15,000 | 15,000 | Direct |
Common Stock | Director Stock Option (right to buy) | $6.49 | 2006-12-13 | 2016-12-13 | 15,000 | 15,000 | Direct |
Common Stock | Stock Option (right to buy) | $4.85 | 2010-06-18 | 2017-06-18 | 15,000 | 15,000 | Direct |
Common Stock | Stock Option (right to buy) | $2.73 | 2017-12-12 | 20,000 | 20,000 | Direct | |
Common Stock | Stock Option (right to buy) | $0.70 | 2019-05-13 | 15,000 | 15,000 | Direct | |
Common Stock, $.001 Par Value | Stock Option (right to buy) | $2.85 | 2019-12-31 | 7,500 | 7,500 | Direct | |
Common Stock, $.001 Par Value | Stock Option (right to buy) | $5.09 | 2011-03-31 | 2020-03-31 | 15,000 | 15,000 | Direct |
Common Stock | Stock Option (right to buy) | $4.77 | 2020-12-31 | 30,000 | 30,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2014-12-22 | 15,029 | 15,029 | Direct |
2016-04-26 | 15,000 | 15,000 | Direct |
2016-12-13 | 15,000 | 15,000 | Direct |
2017-06-18 | 15,000 | 15,000 | Direct |
2017-12-12 | 20,000 | 20,000 | Direct |
2019-05-13 | 15,000 | 15,000 | Direct |
2019-12-31 | 7,500 | 7,500 | Direct |
2020-03-31 | 15,000 | 15,000 | Direct |
2020-12-31 | 30,000 | 30,000 | Direct |
Footnotes
- The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.15 to $5.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
- Includes grants of restricted stock with restrictions that lapsed as to 3,750 shares on December 31, 2010 and 15,000 shares on March 31, 2011 and restrictions that will lapse as to 3,750 shares on December 31, 2011.
- 6,667 shares vest on each of 12/12/08 and 12/12/09; 6,666 shares vest on 12/12/10.
- 5,000 shares vest on each of 12/31/09, 6/30/2010 and 12/31/2010.
- 3,750 shares vest on each of 12/31/2010 and 12/31/2011.
- 10,000 shares vest on each of 12/31/2011, 12/31/2012 and 12/31/2013.